unlicensed
Clinigen buys Idis for £225 million
April 24, 2015Sales and Marketing CBPE Capital, Clinigen, IDIS, unlicensed
UK speciality pharma group Clinigen is paying £225 million to acquire the Surrey-based unlicensed supplier of medicines firm Idis. Unlicensed …
NICE looking into unlicensed and off-label drug use
March 26, 2012Sales and Marketing DoH, NICE, off label, off-label, postcode, unlicensed
NICE is reviewing the use of off-label and unlicensed medicines across the NHS in England. This follows a pilot project …
